Knight Therapeutics | GUD - EPS Earnings Per Share

Stock Price
6.15
Daily Change
0.01 0.16%
Monthly
-6.11%
Yearly
-0.65%
Q1 Forecast
5.95

Knight Therapeutics reported CAD0.03 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 -0.01 0.04 May/07 2026




Eps Change Date
Acasti Pharma USD -0.06 0.15 Sep/2025
Akebia Therapeutics USD 0.03 0.13 Mar/2025
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
Aurora Cannabis CAD -1 0.73 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Cronos Group USD 0.02 0.05 Dec/2025
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Knight Therapeutics CAD 0.03 0.06 Sep/2025
Moderna USD -2.11 1.6 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Organigram Holdings CAD -0.18 0.13 Sep/2025
Organon & Co USD 0.63 0.38 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Tectonic Therapeutic USD -1.02 0.05 Sep/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025